BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 9150699)

  • 1. Greater disorderliness of ACTH and cortisol release accompanies pituitary-dependent Cushing's disease.
    van den Berg G; Pincus SM; Veldhuis JD; Frölich M; Roelfsema F
    Eur J Endocrinol; 1997 Apr; 136(4):394-400. PubMed ID: 9150699
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Apparently complete restoration of normal daily adrenocorticotropin, cortisol, growth hormone, and prolactin secretory dynamics in adults with Cushing's disease after clinically successful transsphenoidal adenomectomy.
    Veldman RG; Frölich M; Pincus SM; Veldhuis JD; Roelfsema F
    J Clin Endocrinol Metab; 2000 Nov; 85(11):4039-46. PubMed ID: 11095430
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Profound amplification of secretory-burst mass and anomalous regularity of ACTH secretory process in patients with Nelson's syndrome compared with Cushing's disease.
    van Aken MO; Pereira AM; van den Berg G; Romijn JA; Veldhuis JD; Roelfsema F
    Clin Endocrinol (Oxf); 2004 Jun; 60(6):765-72. PubMed ID: 15163342
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Patients with Cushing's disease secrete adrenocorticotropin and cortisol jointly more asynchronously than healthy subjects.
    Roelfsema F; Pincus SM; Veldhuis JD
    J Clin Endocrinol Metab; 1998 Feb; 83(2):688-92. PubMed ID: 9467594
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of dexamethasone on the 24-hour profiles of adrenocorticotropin and cortisol in Cushing's syndrome.
    Refetoff S; Van Cauter E; Fang VS; Laderman C; Graybeal ML; Landau RL
    J Clin Endocrinol Metab; 1985 Mar; 60(3):527-35. PubMed ID: 2982900
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hypothalamic abnormalities in patients with pituitary-dependent Cushing's syndrome.
    Stewart PM; Penn R; Gibson R; Holder R; Parton A; Ratcliffe JG; London DR
    Clin Endocrinol (Oxf); 1992 May; 36(5):453-8. PubMed ID: 1319858
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessment of cortisol and ACTH responses to the desmopressin test in patients with Cushing's syndrome and simple obesity.
    Tsagarakis S; Vasiliou V; Kokkoris P; Stavropoulos G; Thalassinos N
    Clin Endocrinol (Oxf); 1999 Oct; 51(4):473-7. PubMed ID: 10583315
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relationship of bioassayable and immunoassayable plasma ACTH and cortisol concentrations in normal subjects and in patients with Cushing's disease.
    Krieger DT; Allen W
    J Clin Endocrinol Metab; 1975 Apr; 40(4):675-87. PubMed ID: 165214
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma ACTH and cortisol responses to TRF, vasopressin or hypoglycemia in cushing's disease and nelson's syndrome.
    Krieger DT; Luria M
    J Clin Endocrinol Metab; 1977 Feb; 44(2):361-8. PubMed ID: 190254
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A comparison of the standard high dose dexamethasone suppression test and the overnight 8-mg dexamethasone suppression test for the differential diagnosis of adrenocorticotropin-dependent Cushing's syndrome.
    Dichek HL; Nieman LK; Oldfield EH; Pass HI; Malley JD; Cutler GB
    J Clin Endocrinol Metab; 1994 Feb; 78(2):418-22. PubMed ID: 8106630
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Desmopressin and hexarelin tests in alcohol-induced pseudo-Cushing's syndrome.
    Coiro V; Volpi R; Capretti L; Caffarri G; Chiodera P
    J Intern Med; 2000 Jun; 247(6):667-73. PubMed ID: 10886488
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diminished and irregular TSH secretion with delayed acrophase in patients with Cushing's syndrome.
    Roelfsema F; Pereira AM; Biermasz NR; Frolich M; Keenan DM; Veldhuis JD; Romijn JA
    Eur J Endocrinol; 2009 Nov; 161(5):695-703. PubMed ID: 19687167
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of desmopressin on ACTH and cortisol secretion in states of ACTH excess.
    Colombo P; Passini E; Re T; Faglia G; Ambrosi B
    Clin Endocrinol (Oxf); 1997 Jun; 46(6):661-8. PubMed ID: 9274696
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The 24-h cortisol secretory pattern in Cushing's syndrome.
    Tourniaire J; Chalendar D; Rebattu B; Fevre-Montange M; Bajard L; Mazenod B; Dechaud H; Abou Samra AB; van Cauter E
    Acta Endocrinol (Copenh); 1986 Jun; 112(2):230-7. PubMed ID: 3017037
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Growth hormone and prolactin are secreted more irregularly in patients with Cushing's disease.
    Veldman RG; Frölich M; Pincus SM; Veldhuis JD; Roelfsema F
    Clin Endocrinol (Oxf); 2000 May; 52(5):625-32. PubMed ID: 10792343
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Early postoperative evaluation in patients with Cushing's disease: usefulness of ovine corticotropin-releasing hormone test in the prediction of recurrence of disease.
    Vignati F; Berselli ME; Loi P
    Eur J Endocrinol; 1994 Mar; 130(3):235-41. PubMed ID: 8156095
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Discriminatory value of the low-dose dexamethasone suppression test in establishing the diagnosis and differential diagnosis of Cushing's syndrome.
    Isidori AM; Kaltsas GA; Mohammed S; Morris DG; Jenkins P; Chew SL; Monson JP; Besser GM; Grossman AB
    J Clin Endocrinol Metab; 2003 Nov; 88(11):5299-306. PubMed ID: 14602765
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Growth hormone secretion in primary adrenal Cushing's syndrome is disorderly and inversely correlated with body mass index.
    van Aken MO; Pereira AM; Frölich M; Romijn JA; Pijl H; Veldhuis JD; Roelfsema F
    Am J Physiol Endocrinol Metab; 2005 Jan; 288(1):E63-70. PubMed ID: 15328071
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A very high dose dexamethasone suppression test for differential diagnosis of Cushing's syndrome.
    al-Saadi N; Diederich S; Oelkers W
    Clin Endocrinol (Oxf); 1998 Jan; 48(1):45-51. PubMed ID: 9509067
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adrenocorticotropin and cortisol responsiveness to thyrotropin-releasing hormone and luteinizing hormone-releasing hormone discloses two subsets of patients with Cushing's disease.
    Pieters GF; Smals AG; Goverde HJ; Pesman GJ; Meyer E; Kloppenborg PW
    J Clin Endocrinol Metab; 1982 Dec; 55(6):1188-97. PubMed ID: 6290524
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.